Inhibition of IGF2BP1 attenuates the progression of endometriosis through PTBP1
Folia Histochemica et Cytobiologica · 2024
DOI: 10.5603/fhc.98213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Histochemica et Cytobiologica, 2024. Verfasst von Yanlin Su und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Chin…. Hauptthemen laut MEDLINE: Endometriosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China.
- Department of Ultrasound, Joint Logistics Support Force 921 Hospital, Changsha, China.
- Department of Obstetrics and Gynecology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China. weixin1017aa@126.com.
Zitieren
APA
Su, Y., Tian, W., Cheng, L., Yin, L., He, X., & Wei, X. (2024). Inhibition of IGF2BP1 attenuates the progression of endometriosis through PTBP1. Folia Histochemica et Cytobiologica. https://doi.org/10.5603/fhc.98213
Vancouver
Su Y, Tian W, Cheng L, Yin L, He X, Wei X. Inhibition of IGF2BP1 attenuates the progression of endometriosis through PTBP1. Folia Histochemica et Cytobiologica. 2024. doi:10.5603/fhc.98213
BibTeX
@article{Su2024,
author = {Su, Yanlin and Tian, Wencai and Cheng, Li and Yin, Ling and He, Xiaoxia and Wei, Xin},
title = {Inhibition of IGF2BP1 attenuates the progression of endometriosis through PTBP1},
journal = {Folia Histochemica et Cytobiologica},
year = {2024},
doi = {10.5603/fhc.98213}
}
EUVIMED